HopeStage
Study directory

Schizophrenia studies

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

Back to overview
More filters: keywords, city, remote
4505studies shown
Showing 121-132 of 4,505
Drug study icon
RecruitingNCT07288333

Evaluation of NBI-1117570 in Inpatient Adults With Schizophrenia

What is this study about?

This study evaluates the safety and effectiveness of NBI-1117570 for people with schizophrenia.

Multiple locations, including Kazanlak
SchizophreniaMedication studyAges 18–55
Countries
United Kingdom, Bulgaria, Romania
Sponsor
Neurocrine Biosciences (Biotech company)
Drug study icon
RecruitingNCT07184619

Evenamide, a Glutamate Release Modulator, as Add-On to Standard of Care in Subjects With Documented Treatment-Resistant Schizophrenia

Official study title

A Phase III, 12-week, Prospective, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center Study to Determine the Efficacy, Safety, and Tolerability of a Dose of 15 mg Bid of Evenamide as add-on in Patients With Documented Treatment-resistant Schizophrenia, Which is Not Adequately Controlled by a Stable Therapeutic Dose of the Patient's Current Antipsychotic Medication(s)

Multiple locations, including Vijayawada
SchizophreniaMedication studyAges 18+
Countries
United States, Argentina, India, + 1 other
Sponsor
Newron Pharmaceuticals SPA
Device study icon
RecruitingNCT04871048

Examining tDCS Effect on Addiction in people with Schizophrenia

Official study title

Examining tDCS Effect on Cannabis Use Disorder in Patients With Schizophrenia A Randomized Controlled Double-blind Exploratory Multicentric Study

In Saint-Priest-en-Jarez
Schizophrenia, AddictionDevice studyAges 18–60
Countries
France
Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Other study type icon
RecruitingNCT07383324

Heat Stress in Individuals With Schizophrenia

Official study title

Impact of Indoor Overheating on Physiological Strain in Individuals With Schizophrenia

In Ottawa
SchizophreniaInterventional studyAges 18–85
Countries
Canada
Sponsor
University of Ottawa
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.